CS167310B2 - - Google Patents

Info

Publication number
CS167310B2
CS167310B2 CS2802A CS280271A CS167310B2 CS 167310 B2 CS167310 B2 CS 167310B2 CS 2802 A CS2802 A CS 2802A CS 280271 A CS280271 A CS 280271A CS 167310 B2 CS167310 B2 CS 167310B2
Authority
CS
Czechoslovakia
Application number
CS2802A
Other languages
Czech (cs)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of CS167310B2 publication Critical patent/CS167310B2/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
    • C07D243/18—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
    • C07D243/24—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
    • C07D243/18—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
    • C07D243/24—Oxygen atoms
    • C07D243/26—Preparation from compounds already containing the benzodiazepine skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
    • C07D243/18—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
    • C07D243/24—Oxygen atoms
    • C07D243/28—Preparation including building-up the benzodiazepine skeleton from compounds containing no hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
    • C07D243/18—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
    • C07D243/24—Oxygen atoms
    • C07D243/30—Preparation including building-up the benzodiazepine skeleton from compounds already containing hetero rings
    • C07D243/32—Preparation including building-up the benzodiazepine skeleton from compounds already containing hetero rings containing a phthalimide or hydrogenated phthalimide ring system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CS2802A 1970-04-23 1971-04-19 CS167310B2 (cg-RX-API-DMAC10.html)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP45035735A JPS494226B1 (cg-RX-API-DMAC10.html) 1970-04-23 1970-04-23

Publications (1)

Publication Number Publication Date
CS167310B2 true CS167310B2 (cg-RX-API-DMAC10.html) 1976-04-29

Family

ID=12450072

Family Applications (1)

Application Number Title Priority Date Filing Date
CS2802A CS167310B2 (cg-RX-API-DMAC10.html) 1970-04-23 1971-04-19

Country Status (6)

Country Link
JP (1) JPS494226B1 (cg-RX-API-DMAC10.html)
AT (1) AT302315B (cg-RX-API-DMAC10.html)
CH (1) CH559730A5 (cg-RX-API-DMAC10.html)
CS (1) CS167310B2 (cg-RX-API-DMAC10.html)
HU (1) HU163631B (cg-RX-API-DMAC10.html)
ZA (1) ZA712391B (cg-RX-API-DMAC10.html)

Also Published As

Publication number Publication date
AT302315B (de) 1972-10-10
ZA712391B (en) 1972-01-26
HU163631B (cg-RX-API-DMAC10.html) 1973-09-27
CH559730A5 (en) 1975-03-14
JPS494226B1 (cg-RX-API-DMAC10.html) 1974-01-31

Similar Documents

Publication Publication Date Title
FR2075893B1 (cg-RX-API-DMAC10.html)
FI49535B (cg-RX-API-DMAC10.html)
CS187316B2 (cg-RX-API-DMAC10.html)
DK135223C (cg-RX-API-DMAC10.html)
FR2079196A1 (cg-RX-API-DMAC10.html)
FR2083578B1 (cg-RX-API-DMAC10.html)
FR2075949A1 (cg-RX-API-DMAC10.html)
DE2056335C3 (cg-RX-API-DMAC10.html)
FR2076009A1 (cg-RX-API-DMAC10.html)
FR2083513B1 (cg-RX-API-DMAC10.html)
DE2118611B2 (cg-RX-API-DMAC10.html)
FR2076041A1 (cg-RX-API-DMAC10.html)
FR2076052B1 (cg-RX-API-DMAC10.html)
FR2085887A1 (cg-RX-API-DMAC10.html)
DE2160147B2 (cg-RX-API-DMAC10.html)
DE2130588C3 (cg-RX-API-DMAC10.html)
FR2075919A2 (cg-RX-API-DMAC10.html)
FR2079193A1 (cg-RX-API-DMAC10.html)
CS149436B2 (cg-RX-API-DMAC10.html)
FR2075903B1 (cg-RX-API-DMAC10.html)
FR2075742A5 (cg-RX-API-DMAC10.html)
FI48117B (cg-RX-API-DMAC10.html)
FR2085846B2 (cg-RX-API-DMAC10.html)
FR2077306A1 (cg-RX-API-DMAC10.html)
FR2059784A5 (cg-RX-API-DMAC10.html)